How a specific gene affects the production of brain cell waste removal particles

Apolipoprotein E genotype modulates brain mitovesicle production, a component of mitochondrial quality control

NIH-funded research Nathan S. Kline Institute for Psych Res · NIH-10942349

This study is looking at how a specific gene called APOE affects tiny particles that help keep brain cells healthy by removing waste, and it aims to help people understand how their genetics might influence brain health as they age or deal with neurodegenerative diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNathan S. Kline Institute for Psych Res NIH-funded
Lab location1 site (Orangeburg, United States)
Project IDNIH-10942349 on NIH RePORTER

What this research studies

This research investigates how the APOE genotype influences the production of mitovesicles, which are tiny particles that help remove waste from brain cells and maintain mitochondrial health. By examining the levels and composition of these mitovesicles in relation to different APOE genotypes, the study aims to understand their role in neurodegenerative diseases and aging. Patients may benefit from insights into how their genetic makeup affects brain health and the potential for new therapeutic strategies targeting mitochondrial quality control.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with varying APOE genotypes, especially those at risk for Alzheimer's disease.

Not a fit: Patients without any genetic predisposition related to APOE or those with unrelated neurological conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for neurodegenerative diseases, particularly for individuals with specific APOE genotypes.

How similar studies have performed: Previous research has shown promising results in understanding the role of extracellular vesicles in brain health, suggesting that this approach may yield valuable insights.

Where this research is happening

Orangeburg, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's disease risk
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.